AIM
JAZZ icon

ARGA Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

ARGA Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
5,187
+15
+0.3% +$3.29K 0.03% 85
2026
Q1 		$978K Hold
5,172
– – 0.03% 75
2025
Q4 		$879K Hold
5,172
– – 0.02% 78
2025
Q3 		$682K Sell
5,172
-4,856
-48% -$582K 0.02% 85
2025
Q2 		$1.06M Hold
10,028
– – 0.03% 80
2025
Q1 		$1.24M Sell
10,028
-2,167
-18% -$283K 0.04% 70
2024
Q4 		$1.5M Hold
12,195
– – 0.05% 59
2024
Q3 		$1.36M Buy
12,195
+5,562
+84% +$610K 0.05% 74
2024
Q2 		$708K Buy
6,633
+3,089
+87% +$340K 0.02% 96
2024
Q1 		$427K Hold
3,544
– – 0.01% 123
2023
Q4 		$436K Buy
+3,544
New +$442K 0.02% 127

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

ARGA Investment Management's JAZZ Position: Q2 2026 in Review

ARGA Investment Management increased its Jazz Pharmaceuticals (JAZZ) stake by 0.29% in Q2 2026, buying an estimated $3.29K and bringing the position to 5,187 shares worth $1.25M. The position accounts for 0.03% of the portfolio, ranked #85.

ARGA Investment Management first reported a position in JAZZ in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.5M in Q4 2024. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • ARGA Investment Management held 5,187 shares of Jazz Pharmaceuticals worth $1.25M as of Q2 2026.
  • ARGA Investment Management bought 15 Jazz Pharmaceuticals shares in Q2 2026, an estimated $3.29K.
  • Jazz Pharmaceuticals made up 0.03% of ARGA Investment Management's portfolio in Q2 2026, its #85 holding.
  • ARGA Investment Management first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • ARGA Investment Management's Jazz Pharmaceuticals position peaked at $1.5M in Q4 2024.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on ARGA Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.